Abstract
OBJECTIVE: The purpose of this study was to determine whether radical surgery in appropriately selected patients who have recurrent rectal cancer can produce significant disease-free survival. PATIENTS AND METHODS: This is a retrospective review of the management of all patients presenting with recurrent local and metastatic rectal cancer at a single institution during an 11-year period. RESULTS: Of 489 patients who underwent curative surgery for primary rectal cancer during the period reviewed, 44 (9 percent) developed recurrent disease at a median interval of 18 (range, 3–60) months after curative surgery. Local pelvic recurrence alone was present in 28 (5.7 percent) patients. Overall survival after diagnosis of recurrent disease was 41 percent (18/44) at a median interval of 15 (range, 2–60) months. Curative resection was performed in 14 (32 percent) patients with a disease-free survival of 86 percent (12/14) at a median of 25 (range, 9–60) months after curative surgery. In comparison, survival in patients who underwent palliative treatment was significantly less (25 vs. 12 months;P <0.05; 95 percent confidence interval, 10, 23 (Mann-Whitney U test)); 20 percent survival at a median of 12 months ranged from 2 to 36 after diagnosis of recurrent disease. Of six patients in the curative group who developed second recurrences, four underwent further curative surgery and are disease-free at a median of 19.5 (range, 12–29) months after surgery. Palliative surgery provided good symptomatic relief and improved quality of life in 11 patients in the palliative group, although there was no survival advantage over those who underwent nonsurgical palliative treatment (n=19). CONCLUSION: In appropriately selected cases, aggressive surgical therapy produces significant disease-free survival in patients with recurrent rectal cancer.
Similar content being viewed by others
References
Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following ‘curative’ surgery for adenocarcinoma of the rectum: clinicopathologic correlation and implications for adjuvant therapy. Cancer 1974;34:1278–92.
Phillipshen SJ, Heilwell M, Quan SH, Sternberg SS, Enker WE. Patterns of pelvic recurrence following definitive rsections of rectal cancer. Cancer 1984;53:1354–62.
McDermott FT, Hughes ES, Pihl E, Johnson WR, Price AB. Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patients. Br J Surg 1985;72:34–7.
Berge T, Ekelund G, Mellner C, Pihl B, Wenckert A. Carcinoma of the colon and rectum in a defined population: an epidemiological, clinical, and postmortem invetigation of colorectal carcinoma and coexisting benign polyps in Mälmo, Sweden. Acta Chir Scand 1973;438(Suppl):1–86.
Karanjia ND, Schache DJ, North WR, Heald RJ. ‘Close shave’ in anterior resection. Br J Surg 1990;77:510–2.
Gilbertsen VA. The results of the surgical treatment of cancer of the rectum. Surg Gynecol Obstet 1962;114:313–9.
Michelassi F, Block GE, Vannucci L, Montag A, Chappell R. A 5 to 20 year follow up and analysis of 250 patients with rectal adenocarcinoma. Ann Surg 1988;208:379–89.
Olson RM, Perencevich NP, Malcolm AW, Chaffey JT, Wilson RE. Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer 1980;45:2969–74.
Sagar PM, Pemberton JH. Surgical management of locally recurrent rectal cancer [review]. Br J Surg 1996;83:293–304.
Schiessel R, Wunderlich M, Herbst F. Local recurrence of colorectal cancer: effects of early detection and aggressive surgery. Br J Surg 1986;73:342–4.
Turk PS, Wanebo HJ. Results of treatment of nonhepatic recurrence of colorectal carcinoma. Cancer 1993;71:4267–77.
Greenway B. Hepatic metastases from colorectal cancer: resection or not? Br J Surg 1988;75:511–9.
Sugarbaker PH. Surgical decision making for large bowel cancer metastatic to the liver. Radiology 1990;174:621–6.
Wagner JS, Adson MA, Van Heerden JA, Adson MH, Ilstrup DM. The natural history of hepatic metastases from colorectal cancer: a comparison with resective treatment. Ann Surg 1984;199:502–8.
Sugarbaker PH, Kemeny N. Management of metastatic liver cancer. Adv Surg 1984;22:1–55.
Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995;221:29–42.
Willett CG, Shellito PC, Tepper JE, Eliseo A, Convery K, Wood WC. Intraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma. Cancer 1991;67:1504–8.
Allen-Mersh TG, Earlam S, Fordy C, Abrahms K, Houghton J. Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases. Lancet 1994;344:1255–60.
Vaughn DJ, Haller DG. Nonsurgical management of recurrent colorectal cancer. Cancer 1993;71:4278–92.
Kodner IJ, Gilley MT, Shemesh EI, Fleshman JW, Fry RD, Myerson RJ. Radiation therapy as definitive treatment for selected invasive rectal cancer. Surgery 1993;114:850–7.
Asbun HJ, Hughes KS. Management of recurrent and metastatic colorectal carcinoma. Surg Clin North Am 1993;1:145–66.
Barr LC, Skene AI, Thomas JM. Metastasectomy. Br J Surg 1992;79:1268–74.
Wanebo HJ, Gaker DL, Whitehill R, Morgan RF, Constable WC. Pelvic recurrence of rectal cancer: options for curative resection. Ann Surg 1987;205:482–95.
Tschmelitsch J, Kronberger P, Glaser K, Klingler A, Bodner E. Survival after surgical treatment of recurrent carcinoma of the rectum. J Am Coll Surg 1994;179:54–8.
Vassilopoulos PP, Yoon JM, Ledesma EJ, Mittelman A. Treatment of recurrence of adenocarcinoma of the colon and rectum at the anastomotic site. Surg Gynecol Obstet 1981;152:777–80.
Beart RW, Martin JK, Gunderson LL. Management of recurrent rectal cancer. Mayo Clin Proc 1986;61:448–50.
Author information
Authors and Affiliations
Additional information
Dr. Ogunbiyi is supported in part by grants from the Ronald Raven Travelling Fellowship of the British Society of Surgical Oncology, The American Society of Colon and Rectal Surgeons Research Foundation International Travelling Fellowship, and the Royal College of Surgeons of England Ethicon Foundation Travelling Fellowship.
Read at the meeting of The American Society of Colon and Rectal Surgeons, Seattle, Washington, June 9 to 14, 1996.
About this article
Cite this article
Ogunbiyi, O.A., McKenna, K., Birnbaum, E.H. et al. Aggressive surgical management of recurrent rectal cancer—Is it worthwhile?. Dis Colon Rectum 40, 150–155 (1997). https://doi.org/10.1007/BF02054979
Issue Date:
DOI: https://doi.org/10.1007/BF02054979